Narula, N., and H. Hamam. “Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill”. Canadian IBD Today, vol. 1, no. S11, Nov. 2023, pp. 2–11, doi:10.58931/cibdt.2023.1S1121.